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Introduction
Recent deep transcriptome sequencing and tiling array studies have uncovered that between 70% and 90% of the human genome are estimated to be pervasively transcribed into mostly non-protein-coding RNA while only less than 2% of the human genome are encoding for proteins. [1] [2] [3] [4] These non-coding RNAs (ncRNAs) comprise small RNAs such as microRNAs 5 as well as long non-coding RNAs (lncRNAs). However, only a minute fraction of the large number of non-coding gene products has been identified or characterized at all. The few individual examples studied in greater detail provide evidence that lncRNAs can execute a broad range of important functions in the cell. [6] [7] [8] Individual long ncRNAs have been implicated e.g., in gene regulation, [9] [10] [11] splicing control, [12] [13] [14] or X chromosome dosage compensation. 15, 16 Notably, some of the lncRNAs have also been implicated in human diseases and most importantly in cancer
The metastasis-associated lung adenocarcinoma transcript 1, MALAT1, is a long non-coding RNA (lncRNA) that has been discovered as a marker for lung cancer metastasis. It is highly abundant, its expression is strongly regulated in many tumor entities including lung adenocarcinoma and hepatocellular carcinoma as well as physiological processes, and it is associated with many RNA binding proteins and highly conserved throughout evolution. The nuclear transcript MALAT-1 has been functionally associated with gene regulation and alternative splicing and its regulation has been shown to impact proliferation, apoptosis, migration and invasion.
here, we have developed a human and a mouse knockout system to study the loss-of-function phenotypes of this important ncRNA. In human tumor cells, MALAT1 expression was abrogated using Zinc Finger Nucleases. Unexpectedly, the quantitative loss of MALAT1 did neither affect proliferation nor cell cycle progression nor nuclear architecture in human lung or liver cancer cells. Moreover, genetic loss of Malat1 in a knockout mouse model did not give rise to any obvious phenotype or histological abnormalities in Malat1-null compared with wild-type animals. Thus, loss of the abundant nuclear long ncRNA MALAT1 is compatible with cell viability and normal development.
Loss of the abundant nuclear non-coding RNA MALAT1 is compatible with life and development
Moritz eißmann, 1, † Tony Gutschner, 2, † Monika hämmerle, 2, 3 stefan Günther, 4 Maïwen caudron-herger, 5 Matthias Groß, 2 peter schirmacher, 3 Karsten Rippe, 5 Thomas Braun, 4 Martin Zörnig 1, * and sven Diederichs 2, where lncRNAs can be deregulated or actively contributing to tumorigenesis. [17] [18] [19] [20] One of the first lncRNA genes discovered was MALAT1, the metastasis-associated lung adenocarcinoma transcript 1, 21 later also referred to as NEAT2 for nuclear-enriched abundant transcript 2. MALAT1 is highly abundant and is expressed in many healthy organs, most strongly in pancreas and lung. 21 Deregulation or a functional role for MALAT1 have now been established in many human cancer entities including lung cancer, hepatocellular carcinoma (HCC), uterine endometrial stromal sarcoma, cervical cancer, breast cancer, osteosarcoma and colorectal cancer, but MALAT1 has also been linked to viral infection or alcohol abuse. [21] [22] [23] [24] [25] [26] [27] [28] [29] In non-small cell lung cancer (NSCLC), MALAT1 is significantly associated with metastasis and serves as an independent prognostic marker for patient survival in early stage lung adenocarcinoma or squamous cell carcinoma of the lung. 21, 30 It promotes cell motility of lung cancer cells 31 and supports generate functional lncRNA knockouts also in human cell lines using zinc finger nucleases to stably integrate RNA destabilizing elements into the human genome site-specifically at the start of an lncRNA gene. 41 Here, we exploit this technique and achieve the efficient silencing of MALAT1 expression in human lung and liver cancer cells. Surprisingly, we demonstrate that the lncRNA MALAT1 is not essential for cell proliferation, cell cycle progression or maintenance of nuclear architecture. Our human loss-of-function model is complemented by a Malat1 knockout mouse model. Malat1-null mice are viable and without any histological signs of developmental defects. Thus, the loss of the highly abundant, nuclear enriched and evolutionarily conserved lncRNA MALAT1 is unexpectedly compatible with life and development.
Results
Depletion of MALAT1, a highly conserved and abundant lncRNA, from human cancer cells. As a first indication for the putative functional relevance of MALAT1, we verified its evolutionary conservation, strong expression and regulation. The lncRNA MALAT1 displayed a high level of sequence conservation throughout 33 mammalian species (Fig. 1A) . In human cells, MALAT1 showed a ubiquitous expression, as it is detected in immortalized primary human cells (1°FF and HEK293) as well as in a broad range of cancer cell lines derived from different tissues (Fig. 1B, left panel) . In addition, MALAT1 was highly abundant and even exceeded the expression of classical housekeeping genes like for example RPLP0 (ribosomal protein, large, P0) (Fig. 1B right panel) .
Based on this pattern of conservation and high expression, we aimed for unraveling the role of MALAT1 in cancer cells as well as in normal development. Therefore, we employed an innovative approach that we recently developed to create highly specific and efficient loss-of-function models of abundant ncRNAs in human cancer cell lines. 41 This approach relies on the stable and site-specific integration of RNA destabilizing elements into the cancer cell genome mediated by zinc finger nucleases (ZFNs) (Fig. 1C) . The ZFN binds to a specific site in the genome and introduces a DNA doublestrand break. When a repair template is present, this break is repaired via homologous recombination allowing a site-specific integration of exogenous sequences. Here, we integrate a cassette comprising the green fluorescent protein (GFP) as a selection marker and a polyadenylation signal (polyA), which functions as the RNA destabilizing element silencing downstream sequences.
Previously, we had only generated A549 bulks of lung adenocarcinoma cells deficient of MALAT1. 41 Here, we extended the loss-of-function model to the liver cancer line HLE (hepatocellular carcinoma). As in A549 cells, MALAT1 was specifically and very efficiently suppressed in stable HLE lines. We obtained single cell MALAT1 knockout clones (KO) in both cancer cell lines with a 1000-fold reduction of MALAT1 expression in A549 KO clones and over 200-fold reduction of MALAT1 in HLE KO clones (Fig. 1D) . This approach depleted the full-length MALAT1 transcript: two different qRT-PCR primer pairs located at either proliferation and invasion of cervical cancer cells by regulating CASPASE-8, CASPASE-3, BAX, BCL-2 and BCL-XL. 22 Furthermore, MALAT1 is functionally important for trophoblast invasion during embryonic development 32 and is associated with synaptogenesis. 33 In summary, MALAT1 is strongly expressed in many tissues, significantly regulated under various physiological and pathological conditions and has been linked to a plethora of functions at the cellular level including proliferation, apoptosis, migration or invasion.
At the molecular level, multiple functions have been proposed for MALAT1. 11, 13, 14, 33, 34 MALAT1 is retained in the nucleus and specifically localizes to nuclear SC35 speckles that play a role in pre-mRNA processing. 35 MALAT1 might regulate alternative pre-mRNA splicing by modulating the phosphorylation levels of serine/arginine splicing factors. 13 Depletion of MALAT1 might alter the pre-mRNA processing of tissue factor or endoglin transcripts. 34 Importantly, MALAT1 might interact with the polycomb repressive complex 1 (PRC1) and thus controls the relocation of growth control genes between polycomb bodies and interchromatin granules, places of silent or active gene expression, respectively. 11 Additionally, MALAT1 RNA is frequently found in many PAR-CLIP experiments as a common interaction partner of RNA binding proteins potentially indicating further functions of MALAT1. 36, 37 Also, the MALAT1 transcript can be processed into a tRNA-like small cytoplasmic RNA, the mascRNA, which might fulfill additional, so far unknown functions. 38 Given all of these divergent potential activities, MALAT1 could function in a cell type-or tissue-specific manner despite its ubiquitous expression. Finally, MALAT1 is highly conserved throughout evolution across many mammalian species, underscoring its potential functional importance (Fig. 1A) .
In summary, these various lines of evidence culminate in the hypothesis that MALAT1 must be an important and most likely essential gene given its high and ubiquitous abundance, its specific regulation and localization patterns, its evolutionary conservation, its many interaction partners, molecular mechanisms and the strong impact of its deregulation on many cellular phenotypes including fundamental processes such as proliferation, migration or invasion.
The functional characterization of lncRNAs has greatly been hampered by a lack of quantitative loss-of-function models. Many lncRNAs-especially if they are nuclear, highly abundant or highly structured-can only be ineffectively targeted by RNA interference. In particular, this is a concern for studies of the highly abundant MALAT1, which was reduced only two-to 4-fold by shRNAs or siRNAs. 30, 31 Accordingly, these approaches make it difficult to distinguish between specific and off-target effects and their results may be prone to false-negative results due to an insufficient knockdown. Genetic knockout models have only been established for very few lncRNAs. For example, the Malat1-neighboring lncRNA Neat1 (nuclear enriched abundant transcript 1), which is essential for paraspeckle formation, has been knocked out in mice, but no phenotype has been reported so far. 39, 40 To overcome this challenge and to create quantitative loss-of-functions models, we have developed a strategy to with similar fractions of cells in G1-, S-and G2/M-phase, respectively ( Fig. 2B and D) . Thus, complete loss of MALAT1 did not impact cell proliferation or cell cycle progression in the lung and liver cancer cells studied here.
Loss of MALAT1 does not affect the global nuclear architecture. A number of studies point to a crucial role of RNA as an architectural factor for shaping the genome and its nuclear environment. 42 Since MALAT1 is a highly abundant RNA strongly enriched in the nucleus, we hypothesized that its loss might affect the structural organization of the nucleus.
35,38 Accordingly, we examined the effect of the MALAT1 knockout with respect to several nuclear subcompartments for which an architectural role of RNA has been reported previously. RNA-dependent changes in nuclear morphology at a resolution of 200-300 nm can be directly detected after fluorescent labeling via evaluation of optical sections acquired by confocal laser scanning microscopy (CLSM) as demonstrated in RNase microinjection experiments. 43 end of the MALAT1 transcript yielded the same negative results for MALAT1 expression in the knockout cell clones (Fig. 1D) .
MALAT1 is not critical for lung or liver cancer cell proliferation. One of the most prominent characteristics of cancer cells is their ability to proliferate-even in the absence of external stimuli due to deregulated signaling cascades. We used our knockout system to analyze the role of MALAT1 in lung and liver cancer cell proliferation. Therefore, we performed cell cycle analyses and proliferation assays with a panel of three MALAT1 wild-type (WT) control cell lines and three KO clones per cell line ( Fig. 2A-D) . As control cells, we included the parental cell lines (A549; HLE) and two WT single cell clones for each cell line that had undergone clonal selection at the same time as the KO clones. We compared the proliferation between WT and KO clones, but could not detect any significant differences in bromodeoxyuridine assays ( Fig. 2A and C) . Additionally, the cell cycle profiles did not significantly differ between WT and KO clones This method allowed the generation of A549 (lung) and hLe (liver) single cell clones that showed a ~1000-fold or ~200-fold reduction of full-length MALAT1, respectively. Given is the average expression measured in three independent experiments +seM. at the pericentromeres, centromeres and telomeres are targeted to these chromosomal loci via RNA. 42 Accordingly, we investigated heterochromatin protein 1 α (HP1α) as a factor involved in establishing and maintaining the repressive state of pericentric heterochromatin and telomere repeat factor 2 (TRF2) as a marker
In the latter study, a compaction of the DNA distribution after DAPI staining revealed that nuclear RNAs are needed to maintain transcriptionally active chromatin compartments in a decondensed conformation. Active RNA polymerase II (RNAP II) can be visualized with an appropriate antibody and associates into distinct nuclear foci referred to as "transcription factories." 44 Accordingly, we tested whether the knockout of MALAT1 resulted in changes of the nuclear distribution of chromatin (DAPI, blue color in merged images in Fig. 3) , RNA (5-ethynyl-uridine label, Fig. 3A ) and RNAP II transcription factories (immunofluorescence, Fig. 3B ). No effect of the MALAT1 knockdown was apparent. In addition, the formation of additional lamin A invaginations in murine cells have been reported upon RNase A treatment. 43 In MALAT1 KO cells, the nuclear envelope structure did not change according to the lamin A staining (Fig. 3C) .
The nucleolus is a site of active RNAP I transcription and is also known to be dependent on RNAP II transcription since its inhibition results in the dissolution of nucleoli into so-called "necklace" structures. 42 The abundant MALAT1 transcript is found as an RNA component in purified nucleoli (Caudron-Herger and Rippe, unpublished), and we reasoned that MALAT1 could play a role for maintaining the structural integrity of the nucleolus. This was tested with UBF (upstream binding factor) as a marker protein for active rDNA genes. UBF reorganizes in the nucleus when the nucleolus structure is disrupted by RNAP II inhibition with α-amanitin. However, no differences were observed here between wild-type and MALAT1 knockout cells (Fig.  3D) .
MALAT1 had previously been closely linked to SC35 nuclear domains, 35 that are also referred to as splicing/nuclear speckles or interchromatin granules. RNA is an important structural component of these nuclear subcompartments. 45, 46 Unmethylated Pc2 (Polycomb 2) protein binds to MALAT1 in SC35 domains and thereby relocates growthcontrol genes to a nuclear environment that promotes their expression. 11 The knockdown of MALAT1 by RNA interference resulted in a redistribution of growth-control gene promoters between PcG bodies and SC35 domains toward the silencing environment of PcG bodies. 11 Thus, another potential function of MALAT1 could be maintaining the structure of SC35 domains and / or mediating interactions of genes with this nuclear subcompartment. However, within the resolution provided by our CLSM analysis, wildtype and knockout cells displayed no significant structural differences with respect to SC35 immunofluorescence (Fig.  3E) . Upon close inspection of confocal three dimensional stacks, it appeared that in some knockout cells the borders of the SC35 domains were slightly more diffuse than in wildtype cells. However, due to the irregular structure of the splicing speckles, we were unable to confirm the statistical significance of this observation.
As discussed previously, a number of proteins that fulfill architectural functions for the formation of heterochromatic regions Figure 4A . Verification of correct Malat1 targeting in ES cells and mice were performed by PCR and Southern Blot analysis ( Fig. 4B and C) .
For our initial analysis, we generated mice with a constitutive knockout of Malat1 by mating of animals harboring one conditional knockout allele with transgenic CMV-Cre deleter mice. The Cre-mediated deletion of Malat1 was confirmed by PCR analysis (Fig. 4D) . 47 The resulting heterozygous knockout mice were bred with each other to obtain Malat1-deficient offspring. Surprisingly, homozygous Malat1 -/-mice were born alive, without indication of embryonic lethality (in total, 15 homozygous Malat1 -/-knockout mice, 21 heterozygous Malat1 +/-knockout animals and 7 wild-type Malat1 +/+ mice were obtained), and these animals displayed no apparent phenotype or pathological limitations when kept under normal stress-free conditions.
Malat1 and Neat1 expression after knockout of Malat1. To validate the effective knockout of Malat1 in the mouse model, we determined the expression of Malat1 transcripts in eight different organs by qRT-PCR (Fig. 5A) . As expected, Malat1 expression was absent in all tissues obtained from homozygous Malat1 knockout mice. Importantly, we used three different amplicons covering the entire length of Malat1 to validate the quantitative loss of Malat1 over the entire transcript. Additionally, the expression of the lncRNA Neat1 was determined using two independent amplicons. Neat1 is a nuclear lncRNA that is essential for paraspeckle formation 39 and represents the neighboring transcript for the telomere shelterin complex. For both proteins, no changes in the nuclear localization were observed in the MALAT1 knockout as compared with the wild-type cell line ( Fig. 3F and G) . Thus, loss of MALAT1 had no detectable impact on the nuclear structures analyzed here. Generation and analysis of Malat1-deficient knockout mice. To investigate the physiological function of Malat1 and to study ducts. Neither female nor male genitals, namely ovary and testis, showed any signs of developmental defects or false organ assembly showing characteristic ovarian follicles and tubular appearance of the testes (Fig. 6G) . Thus, the viable Malat1 KO upstream of Malat1. In only four out of eight organs, we detected a slight, but non-significant induction of Neat1 in Malat1-negative tissues arguing against a hypothetical role of Malat1 in regulating Neat1 expression in cis.
In the human MALAT1-deficient cell lines, NEAT1 expression also remained unaltered (Fig. 5B) .
Histomorphological analysis of WT and Malat1 KO organs. Different organs of Malat1 KO mice were analyzed histomorphologically, including brain, heart, lung, thymus, liver, spleen, pancreas, kidney, intestine and genitals (ovary and testis). Notably, we did not observe any differences related to organ development, organ architecture or organ size. Moreover, no tumors or signs of inflammation were detected in any of the analyzed tissues. Representative pictures of two wild-type (♀, ♂; Brain sections show proper assembly of the brain cortex with pyramidal neurons and oligodendroglial cells (Fig. 6A) . Thymic parenchyma is regularly divided into a cortical portion with densely packed lymphoid cells and a pale stained medullary portion (Fig.  6B) . Lung tissue showed a regular alveolar structure both in WT and Malat1 KO mice without any signs of edema, congestion or emphysema (Fig. 6C) . Liver parenchyma displayed the characteristic lobular organization with hexagonal appearance based on the distributions of portal areas and central venules. No signs of fibrosis or inflammation were visible (Fig.  6D) . Pancreatic tissue of both wildtype and Malat1 knockout mice was regularly subdivided into the exocrine part composed of acini and the pale stained endocrine part with prominent islets of Langerhans (Fig. 6E) . Mouse kidneys of WT and Malat1 KO mice showed a regular assembly of renal cortex showing glomeruli and tubules (Fig. 6F) as well as regularly structured medulla with loops of Henle and collecting Malat1 was quantified with three independent amplicons and Neat1 was quantified using two independent amplicons in lung, spleen, small intestine, kidney, brain, colon, liver and heart of four wild-type (WT) and three Malat1 knockout mice (KO). Gapdh served as reference gene and data was normalized to expression in normal lung which displayed the highest Malat1 and Neat1 expression. Depicted is the average expression +seM (B) NEAT1 was quantified in A549 and hLe cancer cell lines in the parental cell line, two wild-type clones (WT) and three MALAT1 knockout clones (KO) each. RN7SL1 served as reference gene, and data was normalized to expression in the wild-type cells. Depicted is the average expression +seM.
in lung cancer cells before. 41 Here, this methodology also effectively shuts down MALAT1 expression more than 200-fold in human liver cancer cells. Hence, this knockout approach is more effective and more specific than standard RNA interference techniques 30, 31 to deplete this highly abundant lncRNA. In addition, we have generated Malat1 knockout mice using homologous recombination in ES cells to study the physiological function of Malat1 in a whole mammalian organism.
Remarkably, we find MALAT1 to be dispensable for cell viability, proliferation and development in the human and the mouse system, respectively. Given its many reported functional associations, its high expression, regulation and evolutionary conservation, this result is very surprising -in particular considering three previous findings: First, MALAT1 knockdown via RNA interference suppressed proliferation in CaSki cervical cancer cells 22 unraveling a critical role for MALAT1 in this cancer hallmark capability. Second, MALAT1 had been found to govern the transcription of growth control genes. 11 Lastly, MALAT1 had been associated with the trophoblast invasion and placenta function. 32 Despite all of the above mentioned evidence pointing to an important and and potentially essential function of MALAT1, our results clearly demonstrate that its quantitative loss in cancer cells does not affect proliferation and its knockout in mice does not affect viability or normal development.
These apparent discrepancies lead to the hypothesis that MALAT1 could have cell type-specific functions, e.g., might be important for cervical cancer cell proliferation, but not for other cell types including A549 and HLE cells. Depending on further in-depth investigations, it might serve as a paradigm for a lncRNA that is ubiquitously expressed and highly conserved but nevertheless fulfills multiple different, non-essential and tissuespecific functions depending on the cellular environment or the availability of RNA-binding interaction partners.
Our findings also emphasize the need for clean and quantitative genetic loss-of-function models-as exemplified here in both a human as well as a murine system. RNA interference-based knockdown using siRNA or shRNA constructs undisputedly has its value in interrogating a gene for its function in vivo, but these approaches also need to be critically questioned for the efficiency and specificity of their knockdown, for possible off-target effects, and they need to be reproduced with a large number of siRNAs or shRNAs to validate a gene-specific effect. However, definitive answers on the question whether a gene is essential for metazoan development and viability or not can only be derived from knockout models.
While the Malat1 knockout mouse does not display any detectable developmental or lethality phenotype, future studies will be essential to expose these mice to different stresses and environments. Such experiments will potentially reveal differences between wild-type and knockout animals that are due to the loss of MALAT1 and further uncover its function in health and disease. Most interesting will be the studies on potential tumor phenotypes by crossing these mice to different cancer models since MALAT1 has been discovered and most often linked to malignant diseases. The first description of MALAT1 had identified it as a marker in lung cancer metastasis 21 and the mice did not display any signs of developmental or histological abnormalities.
Discussion
The highly abundant, nuclear and evolutionarily conserved lncRNA MALAT1 had been associated with many important cellular functions, linked to molecular mechanisms and was found to be deregulated in many physiological and pathological conditions. 11, 13, [21] [22] [23] [24] [25] [26] [27] [28] [29] [30] [31] [32] [33] 35, 38 Thus, we aimed to generate genetic knockout models to study its function and significance in vivo. Loss-of-function models were successfully established in human cancer cell lines as well as in a knockout mouse model. The zinc finger nuclease-mediated insertion of polyA signals into the MALAT1 locus has been proven to be effective in gene silencing (mouse α-SC35, Sigma-Aldrich), HP1α (Euromedex) and TRF2 (Calbiochem/Merck). For confocal fluorescence imaging, a Leica TCS SP5 confocal laser scanning microscope equipped with a HCX PL APO lambda blue 63x/1.4 NA oil immersion objective was used.
Establishment of an inducible Malat1 knockout mouse model. The mouse Malat1 gene locus was subcloned from the BAC clone RP24-290K10 (BACPAC Resources Center, Children's Hospital Oakland Research Institute; the library RP24 was generated from a single male C57Bl/6J mouse). For the construction of the Malat1 knockout targeting vector, a previously published methodology and protocol was adjusted and used. 48 Briefly, short 500 bp homology arms (one 7 kb upstream of the Malat1 transcription start (5'-arm) and one 1.9 kb downstream of the Malat1 transcript (3'-arm) were amplified by PCR with BAC clone RP24_290K10 as template DNA and inserted via restriction/ligation into the pKoII vector backbone. The BAC clone was electroporated into the recombination-competent E. coli strain SW106. 48 The bacteria are available from the NCI Frederick (https://notendur.hi.is/bmo/Recombineering%20 Website.htm). The bacteria were transformed with the XhoI/Sal1 linearized pKoII vector. In the bacteria, the Malat1 locus with the 7 kb upstream and the 1.9 kb downstream areas was recombined into the pKoII vector backbone. Genomic sequences directly downstream of the murine Malat1 gene were amplified by PCR and inserted in front and behind the FRT-Neo-FRT-loxP cassette human and murine knockout models presented here now allow the in-depth analysis whether MALAT1 might also represent an active player in the metastatic cascade despite not being an essential gene for life and development.
Materials and Methods
Cell culture. A549 lung adenocarcinoma cells were purchased from ATCC (CCL-185). HLE hepatocellular carcinoma cells were a kind gift of Dr. Britta Skawran (Hannover Medical School). Cells were cultivated at 37°C, 5% CO 2 in DMEM + 10% FBS, 0.2 mM Glutamine and antibiotics. A549 and HLE MALAT1 KO cells were generated as previously published.
41
RNA isolation and DNase I digest. RNA from cancer cell lines was isolated using the TRIzol reagent (Life Technologies) according to the manufacturer's recommendations. Samples were treated with DNase I (Roche) for 30 min at 37°C followed by a phenol:chloroform extraction and an ethanol precipitation at -80°C. For mouse tissue RNA isolation from snap frozen samples, the AllPrep RNA/DNA kit (Qiagen) was used according to the manufacturer's recommendations.
Reverse transcription and qRT-PCR. RNA (1-2 μg) was reverse transcribed with RevertAid™ reverse transcriptase (Thermo Scientific) according to the manufacturer's recommendations. Complete removal of genomic DNA was controlled in minus-RT samples in which the reverse transcriptase was replaced by water. For qRT-PCR, the ABI PowerSYBR Green PCR Master Mix was used, and the analysis was performed with an ABI StepOne Plus cycler (Life Technologies). Primer sequences can be found in Table 1 .
Proliferation assay. Cell proliferation was analyzed with the Cell Proliferation ELISA BrdU assay (Roche) according to the manufacturer's recommendations. Briefly, 5 x 10 3 were seeded into black 96-well plates with a clear bottom (Greiner Bio-One). After 48 h, the BrdU solution (10 μM f.c.) was added and the cells were incubated for 6 h. The chemiluminescence was measured with a luminometer (Fluoroskan Ascent FL; Thermo Scientific).
Cell cycle analysis. Cell cycle distribution of exponentially growing cells was analyzed according to standard protocols using Propidiumiodide (PI) staining for DNA content. Briefly, 3 x 10 5 cells were seeded 48 h prior to analysis in 10 cm dishes in normal growth medium. Cells were washed twice in phosphate buffered saline (PBS), scraped off the plates using a rubber policeman, fixed in ethanol, and RNA was digested with RNase A. Cell pellets were resuspended in PI staining solution (40 μg/mL f.c. PI in PBS). Cell cycle profiles were acquired using a BD FACS Calibur and analyzed using the Cell Quest Pro software (Becton Dickinson).
Fluorescence microscopy analysis of nuclear structures. Immunofluorescence, RNA staining via labeling of incorporated ethynyl uridine and staining of the DNA with 4',6-diamidin-2'-phenylindol-dihydrochlorid (DAPI) were conducted after para-Formaldheyde (PFA) fixation as described previously. 43 The antibodies used detected active RNA polymerase II (H5, GeneTex), lamin A (provided by Harald Herrmann-Lerdon, DKFZ), UBF (provided by Ingrid Grummt, DKFZ), SC35 for the Malat1-deleted locus. PCR conditions were as follows: 4 min 95°C, followed by 30 cycles of 30 sec 95°C, 30 sec 56°C, 30 sec 72°C, and a final elongation for 10 min at 72°C. Histomorphological analysis. Mice were sacrificed at the age of 6 weeks. Tissues were resected, fixed in 4% formaldehyde and embedded in paraffin for subsequent staining. Five micrometer sections were cut and stained with hematoxylin and eosin (H&E) according to standard procedures. Histopathologic review of the H&E slides for histopathologic abnormalities was performed using an Olympus BX51 microscope and pictures were taken using a ProgRes ® CMOS camera (Jenoptik). All animal experiments were done in accordance with the Guide for the Care and Use of Laboratory Animals published by the US National Institutes of Health (NIH Publication No. 85-23, revised 1996) and according to the regulations issued by the Committee for Animal Rights Protection of the States of Hessen (Regierungspräsidium Darmstadt).
Statistical analysis. Statistical analyses were performed using Excel 2007. Significance was assessed using T-Tests after determination of the variance equality using an F-Test.
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